• Celltrion identifies antibody candidates against Covid-19 pharmaceutical-technology
    April 15, 2020
    Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the most promise for neutralising the novel coronavirus, SARS-CoV-2, which causes Covid-19.
PharmaSources Customer Service